U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

FIGO Grade 1 Endometrial Mucinous Adenocarcinoma

MedGen UID:
268143
•Concept ID:
C1512250
•
Neoplastic Process

Definition

A primary mucinous adenocarcinoma of the endometrium that contains equal to or less than 5% non-squamous solid areas. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFIGO Grade 1 Endometrial Mucinous Adenocarcinoma

Professional guidelines

PubMed

Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment.
Srisuttayasathien M, Khemapech N
Asian Pac J Cancer Prev 2013;14(12):7669-74. doi: 10.7314/apjcp.2013.14.12.7669. PMID: 24460351
Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.
Gerestein CG, Eijkemans MJ, Bakker J, Elgersma OE, van der Burg ME, Kooi GS, Burger CW
Anticancer Res 2011 Nov;31(11):4043-9. PMID: 22110240

Recent clinical studies

Etiology

Ovarian preservation in gynecologic oncology: current indications and techniques.
Bizzarri N, Pavone M, Loverro M, Querleu D, Fagotti A, Scambia G
Curr Opin Oncol 2023 Sep 1;35(5):401-411. Epub 2023 Jul 13 doi: 10.1097/CCO.0000000000000969. PMID: 37498120
Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
Delvallée J, Cancel M, Body G, Bendifallah S, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Darai E, Ouldamer L
J Gynecol Obstet Hum Reprod 2021 Dec;50(10):102193. Epub 2021 Jul 2 doi: 10.1016/j.jogoh.2021.102193. PMID: 34224900
miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
Fridrichova I, Kalinkova L, Karhanek M, Smolkova B, Machalekova K, Wachsmannova L, Nikolaieva N, Kajo K
Int J Mol Sci 2020 Dec 24;22(1) doi: 10.3390/ijms22010127. PMID: 33374439Free PMC Article
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer.
Tsuyoshi H, Orisaka M, Fujita Y, Asare-Werehene M, Tsang BK, Yoshida Y
BMC Cancer 2020 May 24;20(1):467. doi: 10.1186/s12885-020-06965-4. PMID: 32448194Free PMC Article
Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ, Elshaikh MA, Ali-Fehmi R, Haley MM, Yoon J, Mahan M, Munkarah AR
Int J Gynecol Cancer 2012 Jun;22(5):812-8. doi: 10.1097/IGC.0b013e31824aa877. PMID: 22569105

Diagnosis

Ovarian preservation in gynecologic oncology: current indications and techniques.
Bizzarri N, Pavone M, Loverro M, Querleu D, Fagotti A, Scambia G
Curr Opin Oncol 2023 Sep 1;35(5):401-411. Epub 2023 Jul 13 doi: 10.1097/CCO.0000000000000969. PMID: 37498120
Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features.
Lucas E, Carrick KS
Semin Diagn Pathol 2022 May;39(3):159-175. Epub 2022 Feb 11 doi: 10.1053/j.semdp.2022.02.002. PMID: 35397943
Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
Delvallée J, Cancel M, Body G, Bendifallah S, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Darai E, Ouldamer L
J Gynecol Obstet Hum Reprod 2021 Dec;50(10):102193. Epub 2021 Jul 2 doi: 10.1016/j.jogoh.2021.102193. PMID: 34224900
Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.
Casey L, Singh N
Histopathology 2020 Jan;76(1):37-51. doi: 10.1111/his.13985. PMID: 31846521
Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ, Elshaikh MA, Ali-Fehmi R, Haley MM, Yoon J, Mahan M, Munkarah AR
Int J Gynecol Cancer 2012 Jun;22(5):812-8. doi: 10.1097/IGC.0b013e31824aa877. PMID: 22569105

Therapy

Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment.
Srisuttayasathien M, Khemapech N
Asian Pac J Cancer Prev 2013;14(12):7669-74. doi: 10.7314/apjcp.2013.14.12.7669. PMID: 24460351
Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ, Bristow RE, Ryu HS
Ann Surg Oncol 2012 Dec;19(13):4059-67. Epub 2012 Jul 6 doi: 10.1245/s10434-012-2446-8. PMID: 22766983
The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms.
Heubner M, Wimberger P, Riemann K, Kasimir-Bauer S, Otterbach F, Kimmig R, Siffert W
Oncol Res 2010;18(7):343-7. doi: 10.3727/096504010x12626118079903. PMID: 20377136
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.
Marth C, Windbichler GH, Hausmaninger H, Petru E, Estermann K, Pelzer A, Mueller-Holzner E
Int J Gynecol Cancer 2006 Jul-Aug;16(4):1522-8. doi: 10.1111/j.1525-1438.2006.00622.x. PMID: 16884360

Prognosis

Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
Delvallée J, Cancel M, Body G, Bendifallah S, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Darai E, Ouldamer L
J Gynecol Obstet Hum Reprod 2021 Dec;50(10):102193. Epub 2021 Jul 2 doi: 10.1016/j.jogoh.2021.102193. PMID: 34224900
miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
Fridrichova I, Kalinkova L, Karhanek M, Smolkova B, Machalekova K, Wachsmannova L, Nikolaieva N, Kajo K
Int J Mol Sci 2020 Dec 24;22(1) doi: 10.3390/ijms22010127. PMID: 33374439Free PMC Article
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer.
Tsuyoshi H, Orisaka M, Fujita Y, Asare-Werehene M, Tsang BK, Yoshida Y
BMC Cancer 2020 May 24;20(1):467. doi: 10.1186/s12885-020-06965-4. PMID: 32448194Free PMC Article
Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ
Ann Surg Oncol 2016 Apr;23(4):1279-86. Epub 2016 Jan 29 doi: 10.1245/s10434-015-4959-4. PMID: 26832880
Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ, Elshaikh MA, Ali-Fehmi R, Haley MM, Yoon J, Mahan M, Munkarah AR
Int J Gynecol Cancer 2012 Jun;22(5):812-8. doi: 10.1097/IGC.0b013e31824aa877. PMID: 22569105

Clinical prediction guides

Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
Delvallée J, Cancel M, Body G, Bendifallah S, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Darai E, Ouldamer L
J Gynecol Obstet Hum Reprod 2021 Dec;50(10):102193. Epub 2021 Jul 2 doi: 10.1016/j.jogoh.2021.102193. PMID: 34224900
miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
Fridrichova I, Kalinkova L, Karhanek M, Smolkova B, Machalekova K, Wachsmannova L, Nikolaieva N, Kajo K
Int J Mol Sci 2020 Dec 24;22(1) doi: 10.3390/ijms22010127. PMID: 33374439Free PMC Article
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer.
Tsuyoshi H, Orisaka M, Fujita Y, Asare-Werehene M, Tsang BK, Yoshida Y
BMC Cancer 2020 May 24;20(1):467. doi: 10.1186/s12885-020-06965-4. PMID: 32448194Free PMC Article
Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H, Wu RC, Wang Y, Sinno AK, Miyamoto T, Shiozawa T, Wang TL, Fader AN, Shih IeM
Gynecol Oncol 2015 Nov;139(2):338-44. Epub 2015 Sep 3 doi: 10.1016/j.ygyno.2015.08.025. PMID: 26343160Free PMC Article
Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.
Skirnisdottir I, Seidal T, Åkerud H
Int J Gynecol Cancer 2015 Sep;25(7):1239-47. doi: 10.1097/IGC.0000000000000484. PMID: 26035126Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...